INTELLECTUAL PROPERTY/ LICENSING RIGHTS (Details Narrative) - USD ($)		1 Months Ended
	Oct. 12, 2018	Aug. 20, 2018
Naltrexone Implant Formulation [Member] \| Australia from Trinity Compound Solutions [Member]
Aggregate purchase price, value		$ 236,000
Aggregate purchase price, Shares		10,000
Naltrexone Implant Formulation [Member] \| New Zealand from Trinity Compound Solutions [Member]
Aggregate purchase price, value		$ 236,000
Aggregate purchase price, Shares		20,000
Therakine, Ltd. [Member]
Patent acquired	$ 15,200